Form 8-K - Current report:
SEC Accession No. 0001213900-25-035785
Filing Date
2025-04-28
Accepted
2025-04-28 08:35:12
Documents
31
Period of Report
2025-04-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239689-8k_protara.htm   iXBRL 8-K 37712
2 PRESS RELEASE, DATED APRIL 26, 2025 ea023968901ex99-1_protara.htm EX-99.1 26039
3 INVESTOR PRESENTATION, DATED APRIL 28, 2025 ea023968901ex99-2_protara.htm EX-99.2 20724
4 POSTER PRESENTATION, DATED APRIL 26,2025 ea023968901ex99-3_protara.htm EX-99.3 11555
5 GRAPHIC ex99-1_001.jpg GRAPHIC 2504
6 GRAPHIC ex99-2_001.jpg GRAPHIC 297212
7 GRAPHIC ex99-2_002.jpg GRAPHIC 459587
8 GRAPHIC ex99-2_003.jpg GRAPHIC 157389
9 GRAPHIC ex99-2_004.jpg GRAPHIC 145303
10 GRAPHIC ex99-2_005.jpg GRAPHIC 354533
11 GRAPHIC ex99-2_006.jpg GRAPHIC 258678
12 GRAPHIC ex99-2_007.jpg GRAPHIC 268871
13 GRAPHIC ex99-2_008.jpg GRAPHIC 286561
14 GRAPHIC ex99-2_009.jpg GRAPHIC 228539
15 GRAPHIC ex99-2_010.jpg GRAPHIC 174130
16 GRAPHIC ex99-2_011.jpg GRAPHIC 131568
17 GRAPHIC ex99-2_012.jpg GRAPHIC 230400
18 GRAPHIC ex99-2_013.jpg GRAPHIC 226300
19 GRAPHIC ex99-3_001.jpg GRAPHIC 7737526
  Complete submission text file 0001213900-25-035785.txt   15388919

Data Files

Seq Description Document Type Size
20 XBRL SCHEMA FILE tara-20250426.xsd EX-101.SCH 3017
21 XBRL LABEL FILE tara-20250426_lab.xml EX-101.LAB 34239
22 XBRL PRESENTATION FILE tara-20250426_pre.xml EX-101.PRE 22360
33 EXTRACTED XBRL INSTANCE DOCUMENT ea0239689-8k_protara_htm.xml XML 3691
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

EIN.: 204580525 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36694 | Film No.: 25876211
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)